JDRF funding opportunities

We offer a wide variety of grants and fellowships for qualified researchers in the field of type 1 diabetes and its associated complications. We are currently looking for grant applications in all of the areas listed below.

Requests for applications

(* all dates in dd/mm/yyyy format)

 

Community Innovation opportunities – Request for Applications (RFA) details Application opens* Application deadline Award notification Earliest start date
JDRF Impact Grants, Download application form Passed Passed Passed 01/11/2019

 

Targeted opportunities – Request for Applications (RFA) details Expression of Interest deadline* Expression of Interest outcome Full Application deadline Earliest Award notification Earliest start date
Behavioural Health and Psychology
Telehealth in Type 1 Diabetes behavioral Health and Psychology Passed Passed 21/11/2019 01/03/2020 01/05/2020
Beta Cell Replacement Therapies
3D Bioprinting and Biofabrication of Rationally designed engineered tissue constructs as therapeutic products for treatment of Type 1 Diabetes Passed Passed 14/11/2019 30/04/2020 30/06/2020
Beta Cell Replacement Innovative Awards N/A N/A Passed 31/01/2020 01/03/2020
Beta Cell Regeneration and Survival
Not currently open
Alpha Cell Function
Not currently open
Artificial Pancreas
Not currently open
Complications
Novel Therapeutic Strategies to Prevent or Delay Progression of Early Stage Diabetic Nephropathy 10/12/2019 16/12/2019 27/01/2020 31/07/2020 30/09/2020
Novel Therapeutic Strategies to Prevent or Delay Progression or Early Stage Diabetic Retinopathy 26/11/2019 10/12/2019 14/01/2020 31/05/2020 31/07/2020
Metabolic Control
Metabolic Control Innovative Awards N/A N/A Passed 31/01/2020 01/03/2020
Repositioning Drugs to Improve Metabolic Control in Established Type 1 Diabetes Passed Passed 14/11/2019 31/03/2020 01/07/2020
Safe and Effective Use of SGLT Inhibitors for Type 1 Diabetes Passed 20/11/2019 08/01/2020 31/05/2020 31/08/2020
Immunotherapies
Immunotherapies Innovative Awards N/A N/A Passed 31/01/2020 01/03/2020
Validation of T Cell Biomarkers and Assays for T1D Passed Passed Passed 28/02/2020 01/04/2020
Therapeutic Development and Clinical Testing of Immune Therapies for Type 1 Diabetes Passed Passed Passed 31/03/2020 01/05/2020
Decoding Immune Mediated Diseases – Novel Approaches for Therapeutic Insights Passed Passed 03/12/2019 31/05/2020 01/08/2020
Neoepitoptes in type 1 diabetes: Pathogenesis, staging, and therapeutic utility Passed Passed Passed 30/11/2019 01/01/2020
Prevention
The Role of the Microbiome in Type 1 Diabetes: Pathogenesis and Therapeutic Utility Passed 26/11/2019 07/01/2020 30/04/2020 01/07/2020
Optimisation and Clinical Validation of Islet Autoantibody Assays for Screening for Type 1 Diabetes Risk For Industry (IDDP) only Passed For Academia (SRA) Passed 03/01/2020 01/03/2020
TrialNet
 Not currently open
Pilot Studies
Not currently open

 

Annual opportunities – Request for Applications (RFA) details Application opens* Application deadline Award notification Earliest start date
Postdoctoral Fellowships 01/05/2019 02/07/2019 31/01/2020 01/03/2020
Advanced Postdoctoral Fellowships 01/05/2019 02/07/2019 31/01/2020 01/03/2020
Career Development Awards 01/05/2019 02/07/2019 31/01/2020 01/03/2020
Early Career Patient-Oriented Diabetes Research Awards 01/05/2019 02/07/2019 31/01/2020 01/03/2020
Ongoing opportunities – Request for Applications (RFA) details Application opens* Letter of Intent (LOI) deadline LOI Status Notification Earliest start date
Strategic Research Agreements† N/A 01/08/2019† 16/09/2019 N/A
N/A 04/11/2019† 20/12/2019 N/A
N/A 03/02/2020† 19/03/2020 N/A
Industry Discovery & Development Partnerships Contact  the Scientific Lead for the program in which your project fits.
Conference Grants Submit application to the appropriate Therapeutic Area Program Director, 3-6 months prior to meeting date

All other grant mechanisms

† The SRA mechanism includes Project Concepts, which allow for unsolicited proposals outside of the more focused RFA opportunities. Applications are reviewed on a rolling basis.